ShareHope Medicine: The Company’s 2021 consolidated accounts have been approved by the Board of Directors







Close

Supplied by: SHAREHOPE MEDICINE CO., LTD.

SEQ_NO

2

announcement date

2022/03/25

Announcement time

14:09:19

Topic

 The Company's 2021 consolidated financial
statements have been approved by the Board of Directors

Date of events

2022/03/25

What item it responds to

paragraph 31

Declaration

1.Date of the board of directors submitted or approved:2022/03/25
2.Date of the audit committee approved:2022/03/25
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,850,027
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):833,956
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):258,451
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):267,629
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):193,428
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):232,663
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.04
11.Total assets end of the period (thousand NTD):6,112,808
12.Total liabilities end of the period
(thousand NTD):2,229,514
13.Equity attributable to owners of parent end of the
period (thousand NTD):3,148,802
14.Any other matters that need to be specified:None

Warning

ShareHope Medicine Co. Ltd. published this content on March 25, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on March 25, 2022 06:15:18 UTC.

Public now 2022

All news about SHAREHOPE MEDICINE CO., LTD.

Sales 2020 4,099 million
143M
143M
Net result 2020 248M
8.64 million
8.64 million
Net cash 2020 845 million
29.5 million
29.5 million
2020 PER ratio 15.7x
2020 performance 1.43%
Capitalization 3,201 million
112 million
112 million
EV / Sales 2019 0.86x
EV / Sales 2020 0.72x
# of employees
Floating 64.1%

Chart SHAREHOPE MEDICINE CO., LTD.


Duration :

Period :




ShareHope Medicine Co., Ltd.  Technical Analysis Chart |  MarketScreener

Trends Technical Analysis SHAREHOPE MEDICINE CO., LTD.

Short term Middle term Long term
Tendencies Neutral Neutral Neutral



Evolution of the income statement


Comments are closed.